epoxides 9 and 10, respectively, in the presence of catalysts
4–6 (Scheme 2, Table 1).7 Reactions were carried out at 0 1C in
CH2Cl2, and high dilution (0.9 mM total olefin concentration)
was used to favor intramolecular reaction pathways. A limit-
ing quantity of iodosobenzene oxidant kept substrate concen-
trations close to equimolar levels until the reaction was
quenched with PPh3 after 2 h at a total conversion (9+10)
of 10 Æ 2%, in accordance with previous studies.3 4-Ethyl-
benzoic acid 12 was added in entries 2–4 as a competitive
inhibitor. 2-Acetamidopyridine 11 was added in entries 5 and 7
to equalize amidopyridine functionalities compared to entry 1.
Significantly, analysis of the product mixtures in entries 1
and 5 shows a 4.7 fold preference for epoxide product 9,
whose precursor 7 can form a supramolecular complex with
4, resulting in an inversion of the major epoxide product
depending on whether complex 4 or 5 is used for catalysis.
Competitive binding by 4-ethylbenzoic acid 12 to the receptor
(entries 2–4) gradually leads to diminished selectivity, suggest-
ing that the preferred formation of epoxide 9 in entry 1 is
indeed a consequence of the interaction between the amido-
pyridine group in 4 and the carboxylic acid group in substrate
7 and is not because of a general increase of steric bulk in
the catalyst from the amidopyridine receptor. In entries 6 and
Fig. 1 Global minimum structure obtained from conformation
search simulations of a hydrogen bonded supramolecular complex
between catalyst 4 and 4-vinylbenzoic acid 7.
Scheme 2 Catalytic competition experiment. (i) Catalyst (5 mol%),
PhIO (1 equiv.), n-hexadecane (standard), CH2Cl2, 0 1C, N2, 2 h. Total
olefin concentration: 0.9 mM. Inset: additives to catalytic experiments.
(Scheme 2) was confirmed by isothermal titration calorimetry
(ITC). The carboxylic acid 7 was added to a solution of
catalyst 4 to form a complex predominantly held together
via hydrogen bonding between the carboxylic acid and
the amidopyridine group (Ka (CH2Cl2, 25 1C) = 3090 Æ
360 MÀ1). Consistent with this observation, 2-acetamidopyridine
11 and 7 form a complex with a similar binding constant
(Ka (CH2Cl2, 25 1C) = 1440 Æ 110 MÀ1). Importantly, the
combination of complex 5 and 7 in CH2Cl2 does not result in
measurable binding via ITC. Addition of styrene 8 to a
solution of 2-acetomidopyridine 11 in CH2Cl2 also does not
result in measurable binding. These data all support the
hypothesis that a hydrogen bonded complex forms between
4 and 7 in CH2Cl2 as a consequence of interactions between
the carboxylic acid on 7 and the amidopyridine group on 4.
The influence of noncovalent interactions between 4 and 7
on the epoxide product distribution and enantioselectivity
from a two olefin pool of reactants was determined in a series
of catalytic epoxidation reactions. Equimolar amounts of
olefins 7 and 8 were oxidized to the corresponding chiral
7, (R,R)-[(salen)-MnIII-BArF]
6 shows similar epoxide
distributions and turnover as complex 5, confirming the
preference for styrene oxide formation by this catalytic moiety.
Significant variations in enantioselectivity are observed for
both epoxide 9 and 10 in the different catalytic runs, which are
attributed to a combination of hydrogen bonding and other
interactions that affect epoxide enantioselectivity.7
In conclusion, the assembly of a receptor and a catalyst in a
tweezer fashion via a highly convergent metal coordination
linker is reported for the first time, resulting in a supra-
molecular complex with a specific substrate that leads to its
preferential epoxidation compared to a substrate that does not
bind to the receptor. Use of triple-decker structures6 and a
larger pool of hemilabile P,S receptor, cofactor and catalyst
ligands should lead to improved catalytic selectivities.
We acknowledge the NSF, ARO, AFOSR, and DDRE for
financial support of this research and IMSERC (Northwestern U.)
for analytical services. C.A.M. is grateful for
a NIH
Director’s Pioneer Award. A.B.B. is grateful for a NIH
Postdoctoral fellowship (1F32CA136148-01). P.A.U. thanks
Dr Christopher Oliveri, Dr Hyojong Yoo and Dr Sebastian
Peter for helpful discussions.f
Table 1 Product distribution and enantiomeric excess (ee) of chiral
epoxides following catalytic epoxidation reactions. Catalytic reactions
were carried out in duplicate or triplicate. Conversion and the absolute
ee of 10 were determined via chiral gas chromatography (GC) after
carboxylic acid methylation. Standard deviations for conversion:
r0.7%; ee of 10: r2%; approximate accuracy for ee of 9: Æ 5%
(determined using a chiral 1H NMR shift reagent after purification).
Equiv., conversion and mol% are given with respect to total
olefin concentration
Notes and references
1 M. G. Malkowski, S. L. Ginell, W. L. Smith and R. M. Garavito,
Science, 2000, 289, 1933–1938.
2 R. Breslow, Acc. Chem. Res., 1980, 13, 170–177; S. Das,
G. W. Brudvig and R. H. Crabtree, Chem. Commun., 2008,
413–424.
3 R. Breslow, Y. Huang, X. Zhang and J. Yang, Proc. Natl. Acad.
Sci. U. S. A., 1997, 94, 11156–11158; L. G. Mackay, R. S. Wylie
and J. K. M. Sanders, J. Am. Chem. Soc., 1994, 116, 3141–3142;
S. Das, C. D. Incarvito, R. H. Crabtree and G. W. Brudvig,
Science, 2006, 312, 1941–1943; S. Das, G. W. Brudvig and
R. H. Crabtree, J. Am. Chem. Soc., 2008, 130, 1628–1637;
T. Smejkal and B. Breit, Angew. Chem., Int. Ed., 2008, 47,
Conversion (%) Conversion (%)
10 (absolute ee)
Entry Catalyst Additive
9 (relative ee)
1
2
3
4
5
6
7
4
4
4
4
5
6
6
None
12 (0.5 equiv.) 6.2 (À28%)
6.9 (À26%)
3.4 (À13%)
3.6 (À12%)
3.9 (À19%)
4.2 (À21%)
6.7 (À12%)
7.3 (+5%)
6.3 (+6%)
12 (2.5 equiv.) 4.2 (À28%)
12 (5 equiv.)
11 (5 mol%)
None
3.5 (À24%)
2.9 (+5%)
3.8 (+34%)
3.5 (+31%)
´
3946–3949; S. R. Shenoy, F. R. Pinacho Crisostomo, T. Iwasawa
and J. Rebek, Jr., J. Am. Chem. Soc., 2008, 130, 5658–5659;
11 (5 mol%)
ꢀc
This journal is The Royal Society of Chemistry 2009
5122 | Chem. Commun., 2009, 5121–5123